JUST RELEASED!
The 2026 Update of the Surviving #Sepsis Campaign Guidlines is now online!
Permanent Free Access
Adult: https://t.co/Noup1PiXmZ
Children: https://t.co/zN6pifl8FT
Effective rate control in critically ill patients is challenging. Evidence continues to support landiolol’s rapid onset, short half-life and favourable haemodynamic profile in critical care. Read more: https://t.co/Fg5TeMWlkx #ICU#ISICEM#AOPHealth
Landi-SEP - the ultra-short-acting beta-blocker landiolol was effective in reducing and maintaining HR without increasing vasopressor requirements after 24 h in patients with septic shock and persistent tachycardia. Dr Paulo Mergulhão explains more here: https://t.co/y234jAiJ9K
Growing evidence supports earlier, targeted use of vasopressin in septic shock. From studies to AI-driven models, the message is clear: start #vasopressin sooner, at lower norepinephrine doses & before severe metabolic derangement sets in. Read here: https://t.co/8ZJP0KvX9c
“Non sono stati Hitler o Himmler a deportarmi, picchiarmi, ad uccidere i miei familiari. Furono il lattaio, il vicino di casa, il calzolaio, il dottore, a cui fu data un'uniforme e credettero di essere la razza superiore.”
-- Karl Stojka, sopravvissuto ad Auschwitz
#Memoria
…ho pubblicato una riflessione su cosa faccio come mentor (spoiler: non sono una coach 😊).
Mi farebbe piacere sapere cosa ne pensi, se hai 2 minuti... 😁 [https://t.co/DaGvUD5xiq ]
European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2025: post-resuscitation care. More here: https://t.co/0y6JVW1aJX @ESICM#LIVES2025
Intensive Talks by AOP Health kicks off Sept 24. First session: real-world cases and #ICU strategies. Don’t miss it—register here: https://t.co/VWyMfUqx7W #sepsis#AOPHealth
Landiolol for heart rate control in adults with septic shock & persistent tachycardia
🫀effective in ⬇️/maintaining HR, no ⬆️vasopressor requirements
⚖️ no differences in adverse events & outcomes
🪦 trend for ⬇️ mortality if AF, ⬆️ if sinus tachycardia
🔓 https://t.co/7yO1ts7yqS
“Il messaggio emerso è chiaro: una gestione più fisiologica, personalizzata e integrata della sepsi e dello shock settico può migliorare significativamente la sopravvivenza e la qualità dell’assistenza.”
https://t.co/7Ntnr4jbMS
Un cuore d’oro cerca una famiglia che lo ami davvero
Meet Charlie - 10 anni di saggezza e dolcezza infinita 💕
Questo splendido signore a quattro zampe si trova a Olbia e sogna una seconda possibilità nella vita.
A strategic alliance between #AOPHealth and RHEACELL GmbH & Co. KG, a pioneering biotech company specialising in the development of stem cell therapies. Read more as to what this partnership means for the future of patients' unmet medical needs: https://t.co/pKkNTz4ait
🔍Check some EACTAIC Echo Course Scientific Programme's Insights and do not miss this inspiring and productive experience at Niguarda Hospital in Milan, June 14-17, 2025.
🫀 We’ve taken your feedback from past years to heart and have worked closely with our faculty to build a program that is engaging, relevant, and impactful. This event is not only an educational opportunity but also a chance to connect with experts, share ideas, and advance the field of perioperative ultrasound together.
📘 Download the full programme here: https://t.co/ndQG776Rrf
📝 Hurry up and register here: https://t.co/M8PPKUJpxs
Join #AOPHealth at booth #1546, May 19-21 at the NTI & Critical Care Exposition in New Orleans. More details here: https://t.co/czDCZiMw82
#criticalcare#NeedsScienceTrust